|
PKD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7080781233858E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2518996950206E-10 |
| Normal-vs-Stage2 |
1.02420000258618E-08 |
| Normal-vs-Stage3 |
9.86899451049794E-11 |
| Normal-vs-Stage4 |
1.64769997645919E-09 |
| Stage1-vs-Stage2 |
2.254600E-01 |
| Stage1-vs-Stage3 |
1.882620E-01 |
| Stage1-vs-Stage4 |
1.464160E-01 |
| Stage2-vs-Stage3 |
8.286200E-01 |
| Stage2-vs-Stage4 |
9.853200E-01 |
| Stage3-vs-Stage4 |
8.351400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.18396436888224E-12 |
| Normal-vs-AfricanAmerican |
2.632000E-04 |
| Normal-vs-Asian |
4.5050000000435E-06 |
| Caucasian-vs-AfricanAmerican |
6.629200E-01 |
| Caucasian-vs-Asian |
7.046200E-01 |
| AfricanAmerican-vs-Asian |
9.024200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55909737845172E-11 |
| Normal-vs-Female |
2.94853030879949E-12 |
| Male-vs-Female |
6.359400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.32030003491468E-09 |
| Normal-vs-Age(41-60Yrs) |
4.72220040848015E-11 |
| Normal-vs-Age(61-80Yrs) |
8.01891886226258E-12 |
| Normal-vs-Age(81-100Yrs) |
3.819500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.004000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.543200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.502200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.694400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.062000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.382000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.083600E-01 |
| Classical-VS-Follicular |
6.404000E-04 |
| Classical-VS-Other |
5.894200E-01 |
| Classical-VS-Normal |
4.64239979791614E-10 |
| Tall-VS-Follicular |
5.599400E-01 |
| Tall-VS-Other |
7.750000E-01 |
| Tall-VS-Normal |
5.53460000052297E-08 |
| Follicular-VS-Other |
5.595800E-01 |
| Follicular-VS-Normal |
3.90154575313773E-12 |
| Other-VS-Normal |
1.069870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18793863634892E-14 |
| Normal-vs-N1 |
4.51559999947726E-07 |
| N0-vs-N1 |
2.638800E-01 |
|
|
